Signet Financial Management, LLC Danaher Corp Transaction History

Signet Financial Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$185.1 - $233.13 $128,644 - $162,025	-695 Reduced 16.52%	3,513 $812,000
Q3 2023 Oct 25, 2023	SELL	$233.08 - $265.59 $6,060 - $6,905	-26 Reduced 0.61%	4,208 $1.04 Million
Q2 2023 Jul 18, 2023	BUY	$224.99 - $256.14 $12,374 - $14,087	55 Added 1.32%	4,234 $1.02 Million
Q1 2023 Apr 17, 2023	BUY	$239.75 - $277.0 $149,604 - $172,848	624 Added 17.55%	4,179 $1.05 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $74,115 - $86,663	-307 Reduced 7.95%	3,555 $943,000
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $20,011 - $122,099	-81 Reduced 2.05%	3,862 $998,000
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $2,371 - $2,996	10 Added 0.25%	3,943 $1 Million
Q1 2022 May 13, 2022	BUY	$257.27 - $315.76 $2,315 - $2,841	9 Added 0.23%	3,933 $1.15 Million
Q4 2021 Feb 11, 2022	BUY	$292.08 - $329.01 $33,881 - $38,165	116 Added 3.05%	3,924 $1.29 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $1.04 Million - $1.27 Million	3,808 New	3,808 $1.16 Million

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $174B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Signet Financial Management, LLC with notifications on news.